Penetration of β-lactamase inhibitors into the periplasm of Gram-negative bacteria

被引:8
作者
Farmer, TH
Degnan, BA
Payne, DJ
机构
[1] SmithKline Beecham Pharmaceut, Antiinfect Res UP1345, Collegeville, PA 19426 USA
[2] SmithKline Beecham Pharmaceut, Betchworth RH3 7AJ, Surrey, England
关键词
beta-lactamase inhibitor; permeability; clavulanic acid;
D O I
10.1111/j.1574-6968.1999.tb13635.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The effectiveness of a beta-lactamase inhibitor/beta-lactam combination against Gram-negative pathogens depends on many interplaying factors, one of which is the penetration of the inhibitor across the outer membrane. In this work we have measured the relative penetrations of clavulanic acid, sulbactam, tazobactam and BRL 42715 into two strains of Escherichia coli producing TEM-1 beta-lactamase, two strains of Klebsiella pneumoniae producing either TEM-1 or K-1, and two strains of Enterobacter cloacae each producing a Class C beta-lactamase. It was shown that clavulanic acid penetrated the outer membranes of all these strains more readily than the other beta-lactamase inhibitors. For the strains of E. coli and K. pneumoniae clavulanic acid penetrated approximately 6 to 19 times more effectively than tazobactam, 2 to 9 times more effectively than sulbactam and 4 to 25 times more effectively than BRL 42715. The superior penetration of clavulanic acid observed in this study is likely to contribute to the efficacy of clavulanic acid/beta-lactam combinations in combating beta-lactam resistant bacterial pathogens. (C) 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 15 条
[2]   Amoxycillin clavulanate: An assessment after 15 years of clinical application [J].
Ball, P ;
Geddes, A ;
Rolinson, G .
JOURNAL OF CHEMOTHERAPY, 1997, 9 (03) :167-198
[3]   RESISTANCE CAUSED BY DECREASED PENETRATION OF BETA-LACTAM ANTIBIOTICS INTO ENTEROBACTER-CLOACAE [J].
BUSH, K ;
TANAKA, SK ;
BONNER, DP ;
SYKES, RB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (04) :555-560
[4]   INVITRO EVALUATION OF BRL 42715, A NOVEL BETA-LACTAMASE INHIBITOR [J].
COLEMAN, K ;
GRIFFIN, DRJ ;
PAGE, JWJ ;
UPSHON, PA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1580-1587
[5]   CORRELATION OF THE EFFECT OF BETA-LACTAMASE INHIBITORS ON THE BETA-LACTAMASE IN GROWING CULTURES OF GRAM-NEGATIVE BACTERIA WITH THEIR EFFECT ON THE ISOLATED BETA-LACTAMASE [J].
EASTON, CJ ;
KNOWLES, JR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (03) :358-363
[6]  
EMMERSON AM, 1993, INT CLIN PRACT SER, V5, P8
[7]   QUANTITATIVE RELATIONSHIP BETWEEN SENSITIVITY TO BETA-LACTAM ANTIBIOTICS AND BETA-LACTAMASE PRODUCTION IN GRAM-NEGATIVE BACTERIA .2. NON-STEADY-STATE TREATMENT AND PROGRESS CURVES [J].
FRERE, JM ;
JORIS, B ;
CRINE, M ;
MARTIN, HH .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (09) :1427-1433
[8]   QUANTITATIVE RELATIONSHIP BETWEEN SENSITIVITY TO BETA-LACTAM ANTIBIOTICS AND BETA-LACTAMASE PRODUCTION IN GRAM-NEGATIVE BACTERIA .1. STEADY-STATE TREATMENT [J].
FRERE, JM .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (09) :1415-1426
[9]   A NOVEL METHOD FOR EVALUATING THE OUTER-MEMBRANE PERMEABILITY TO BETA-LACTAMASE-STABLE BETA-LACTAM ANTIBIOTICS [J].
KOJO, H ;
SHIGI, Y ;
NISHIDA, M .
JOURNAL OF ANTIBIOTICS, 1980, 33 (03) :310-316
[10]   PORIN CHANNELS IN ESCHERICHIA-COLI - STUDIES WITH BETA-LACTAMS IN INTACT-CELLS [J].
NIKAIDO, H ;
ROSENBERG, EY ;
FOULDS, J .
JOURNAL OF BACTERIOLOGY, 1983, 153 (01) :232-240